Musculoskeletal ageing and primary prevention

被引:31
作者
Nedergaard, Anders [1 ,2 ]
Henriksen, Kim [1 ]
Karsdal, Morten A. [1 ]
Christiansen, Claus [1 ]
机构
[1] Nord Biosci Biomarkers & Res, DK-2720 Herlev, Denmark
[2] Bispebjerg Hosp, Inst Sports Med Copenhagen, DK-2400 Copenhagen NW, Denmark
关键词
osteoporosis; sarcopenia; prevention; primary prevention; hormone replacement therapy; SARM; SERM; SKELETAL-MUSCLE HYPERTROPHY; LIFE-STYLE INTERVENTION; SATELLITE CELL CONTENT; DIFFERENT FIBER TYPES; ELDERLY-MEN; CANCER CACHEXIA; OLDER-ADULTS; STEM-CELLS; POSTMENOPAUSAL OSTEOPOROSIS; AROMATASE DEFICIENCY;
D O I
10.1016/j.bpobgyn.2013.06.001
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Loss of musculoskeletal mass and function is a natural ageing trait, reinforced by an unhealthy life style. Loss of bone (osteoporosis) and muscle (sarcopaenia) are conditions whose prevalence are increasing because of the change in population distribution in the western world towards an older mean age. Improvements in lifestyle factors, such as diet, smoking and exercise, are the most powerful tools to combat this decline efficiently; however, public health interventions aimed at tackling these problems have shown abysmal success at the population level, mostly due to failure in compliance. With these issues in mind, we believe that the primary prevention modality in coming decades will be pharmacological. We review the basic biology of musculoskeletal ageing and what measures can be taken to prevent ageing-associated loss of musculoskeletal mass and function, with particular emphasis on pharmacological means. (C) 2013 Published by Elsevier Ltd.
引用
收藏
页码:673 / 688
页数:16
相关论文
共 110 条
[1]
Akune Toru, 2013, Clin Calcium, V23, P83, DOI CliCa13018391
[2]
MUSCLE MORPHOLOGY, ENZYMATIC-ACTIVITY, AND MUSCLE STRENGTH IN ELDERLY MEN - A FOLLOW-UP-STUDY [J].
ANIANSSON, A ;
HEDBERG, M ;
HENNING, GB ;
GRIMBY, G .
MUSCLE & NERVE, 1986, 9 (07) :585-591
[3]
Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives [J].
Baron, Roland ;
Hesse, Eric .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :311-325
[4]
No donor age effect of human serum on collagen synthesis signaling and cell proliferation of human tendon fibroblasts [J].
Bayer, Monika L. ;
Schjerling, Peter ;
Biskup, Edyta ;
Herchenhan, Andreas ;
Heinemeier, Katja M. ;
Doessing, Simon ;
Krogsgaard, Michael ;
Kjaer, Michael .
MECHANISMS OF AGEING AND DEVELOPMENT, 2012, 133 (05) :246-254
[5]
Ovarian cancer and hormone replacement therapy in the Million Women Study [J].
Beral, Valerie ;
Bull, Diana ;
Green, Jane ;
Reeves, Gillian .
LANCET, 2007, 369 (9574) :1703-1710
[6]
Bilezikian JP, 2009, J BONE MINER RES, V24, P373, DOI [10.1359/JBMR.090105, 10.1359/jbmr.090105]
[7]
Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency [J].
Bilezikian, JP ;
Morishima, A ;
Bell, J ;
Grumbach, MM .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :599-603
[8]
HOW TO MANAGE POSTMENOPAUSAL OSTEOPOROSIS? [J].
Body, J. J. .
ACTA CLINICA BELGICA, 2011, 66 (06) :443-447
[9]
The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms [J].
Bondesen, BA ;
Mills, ST ;
Pavlath, GK .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 290 (06) :C1651-C1659
[10]
A temporal switch from Notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis [J].
Brack, Andrew S. ;
Conboy, Irina M. ;
Conboy, Michael J. ;
Shen, Jeanne ;
Rando, Thomas A. .
CELL STEM CELL, 2008, 2 (01) :50-59